Effect of fluorinated quinolones on heat-labile toxin production by Escherichia coli.
Pessina
A
A
Institute of Medical Microbiology, Via Mangiagalli, 31 20133 Milano, Italy.
Neri
M G
MG
Iannetta
M
M
Mineo
E
E
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001427:Bacterial Toxins / Q000378:metabolism*; D002939:Ciprofloxacin / Q000494:pharmacology*; D004768:Enterotoxins / Q000378:metabolism*; D004926:Escherichia coli / Q000187:drug effects*; D029968:Escherichia coli Proteins / Q000378:metabolism*; D024841:Fluoroquinolones / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin / Q000494:pharmacology*; D015366:Pefloxacin
D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D002939:Ciprofloxacin; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D024841:Fluoroquinolones; D015242:Ofloxacin; D015366:Pefloxacin; C027538:heat-labile enterotoxin, E coli